NG GEORGE K (Chief Executive Officer) purchased 24.6% of their position (3.06K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $5.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/1/2026ACC: 0000897069-26-001480
Officer· Chief Executive Officer
Since Aug 2023
+3.06K
Net shares
Net buyer
$5.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.06K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.06K
Price / share
$1.93
Trade value
$5.90K
% of position
24.6%
7/1/2026
12.44K→15.49K
Total
Net shares
+3.06K
Net value
$5.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | P · Purchase | +3.06K | $1.93 | $5.90K | 24.6% | 12.44K | 15.49K |
| Total | +3.06K | $5.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.49K
Common Stock
IndirectShares owned800.00
Total
4.29K indirect4.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.49K | Indirect |
| Common Stock | 800.00 | Indirect |
| Total | 4.29K | 4.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported